ClinicalTrialsFinder
RecruitingNCT06851910

Intravenous Lacosamide for the Treatment of Acute Pain in Trigeminal Neuralgia

Intravenous Lacosamide for the Treatment of Acute Pain in Trigeminal Neuralgia: A Prospective Observational Study

Sponsor

Hospital Universitari de Bellvitge

Enrollment

20 participants

Start Date

Apr 21, 2025

Study Type

OBSERVATIONAL

Conditions

Trigeminal Neuralgia

Summary

This prospective observational study evaluates the effectiveness and safety of intravenous lacosamide as a rescue treatment for acute pain in patients presenting to the emergency department with trigeminal neuralgia

Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • All patients diagnosed with trigeminal neuralgia who present to the emergency department of Hospital de Bellvitge for an acute pain exacerbation and are prescribed intravenous lacosamide as symptomatic pain treatment, according to the treating physician's discretion, will be considered for inclusion.
  • Diagnosis of classical or idiopathic trigeminal neuralgia according to the criteria of the International Classification of Headache Disorders (ICHD-3).
  • Age over 18 years.
  • Signed informed consent.

Exclusion Criteria4

  • Contraindication for treatment with lacosamide (previous hypersensitivity reaction, known atrioventricular block).
  • Mental or psychiatric illness that interferes with the ability to understand and sign the informed consent.
  • Language barrier.
  • Lack of cooperation.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLacosamide

Patients will be included if they are prescribed intravenous lacosamide for their trigeminal neuralgia exacerbation

Locations(1)

Hospital de Bellvitge

L'Hospitalet de Llobregat, Barcelona, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06851910

Related Trials

Neurosurgical Outcome Network

NCT0672402927 locations

The Will Erwin Headache Research Center - Cluster Headache Study

NCT029103231 location

OnabotulinumtoxinA for Trigeminal Neuralgia

NCT062168861 location

Trigeminal Evoked Responses to Improve Rhizotomy

NCT057380961 location

Trigeminal Neuralgia Electrophysiology

NCT052694721 location